Peptide Macrocyclization via Diels-Alder for Aqueous Structural Stabilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing chemical strategies for stabilizing peptide secondary structures are often incompatible with diverse structures and aqueous conditions, limiting their application in synthesizing bioactive ligands.
Innovation Solution
Incorporation of reactive functional groups into amino acids for macrocyclic peptide formation through intramolecular Diels-Alder cycloadditions, allowing for the synthesis of macrocyclic compounds with stabilized loop, helical, and other desirable peptide folds, including bicyclic or higher order cyclized peptides.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If traditional alkylation or acylation reactions are used to stabilize peptide secondary structures, then structural stability is improved, but compatibility with diverse structures and aqueous conditions deteriorates
Solution Approach 1:
The patent applies parameter changes by transitioning from traditional alkylation/acylation reactions to Diels-Alder cycloaddition reactions. This chemical reaction parameter change enables the formation of stable macrocyclic peptide structures while maintaining compatibility with aqueous conditions and diverse peptide sequences. The Diels-Alder reaction conditions (aqueous buffer, physiological pH, room temperature) represent a fundamental parameter shift that resolves the contradiction between stability and versatility.
Solution Approach 2:
The patent substitutes traditional peptide stabilization mechanisms (alkylation of cysteine, acylation of lysine) with a completely different chemical mechanism - the Diels-Alder cycloaddition between diene and dienophile functional groups. This mechanism substitution allows for stable macrocyclic formation without relying on nucleophilic attack on electrophilic centers, thereby achieving both structural stability and broad compatibility with diverse peptide structures and aqueous environments.
2Reliability
If metal-catalyzed bond formation strategies (olefin metathesis, Huisgen ligation) are used to staple peptides, then binding affinity and pharmacokinetics are improved, but compatibility with diverse structures and natural functionalities deteriorates
Solution Approach 1:
The patent replaces metal-catalyzed bond formation mechanisms (olefin metathesis requiring transition metals, copper-catalyzed Huisgen ligation) with a thermal Diels-Alder cycloaddition mechanism. This substitution eliminates the need for metal catalysts and their associated constraints, enabling the reaction to proceed under mild aqueous conditions with broad substrate tolerance. The thermal activation mechanism provides universality across diverse peptide sequences and functional groups while maintaining the desired binding affinity and pharmacokinetic properties.
Solution Approach 2:
The patent changes the reaction condition parameters from those required by metal-catalyzed methods (anhydrous conditions, inert atmospheres, metal catalysts, specific temperature ranges) to Diels-Alder conditions (aqueous buffer, physiological pH, room temperature or mild heating). This parameter transformation resolves the contradiction by achieving high reliability in binding and pharmacokinetics through macrocyclization while simultaneously gaining versatility with diverse structures and natural functionalities.
3Stability of the object's composition
If maleimide cross-linkers are used to stabilize peptide structures, then some structural stability is achieved, but epimerization and hydrolysis complicate the product mixture
Solution Approach 1:
The patent substitutes the maleimide thiol addition mechanism (which proceeds through a reactive intermediate prone to epimerization and hydrolysis) with a concerted Diels-Alder cycloaddition mechanism. The Diels-Alder reaction occurs through a single concerted step with a cyclic transition state, avoiding reactive intermediates that lead to side reactions. This mechanism substitution ensures high manufacturing precision by producing clean reaction mixtures with defined stereochemistry (endo/exo selectivity) and no epimerization or hydrolysis complications.
Solution Approach 2:
The patent employs beforehand cushioning by designing the peptide sequence to include specific diene and dienophile functional groups at predetermined positions. This pre-planned placement ensures that the Diels-Alder reaction occurs intramolecularly to form the desired macrocycle, preventing intermolecular side reactions and ensuring high product purity. The stereochemical outcome is predetermined by the reaction mechanism and substrate geometry, cushioning against epimerization issues that plague other methods.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The Diels-Alder cycloaddition reaction stabilizes peptide structures, enhancing binding affinity, cellular uptake, and pharmacokinetics, and is compatible with a range of chemical environments, including aqueous solutions.
Implementation Method 1
Incorporation of reactive functional groups into amino acids for macrocyclic peptide formation through intramolecular Diels-Alder cycloadditions
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present disclosure provides macrocyclic and macrobicyclic peptides with secondary structures that are stabilized over the corresponding non-cyclic peptides. The macrocyclic and macrobicyclic peptides are formed from peptides with adduct-forming, complementary reactive side chain moieties.